The GALAFOLD brand, founded in 2014 (United States), from 7 sister brands and 2214 competing brands. GALAFOLD is owned by Amicus Therapeutics, listed on the stock exchange of New York GALAFOLD belongs to the Biotechnology business sector.
Investment simulator :
Portfolio valuation
Amicus Therapeutics
(GALAFOLD)
over 5 years*
USD 8.20